ALKS (STOCKS)
Alkermes Inc. plc
$44.360000
+0.080000 (+0.18%)
Prev close: $44.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard F. Pops
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,393.75M
- Employees
- 1,800
- P/E (TTM)
- 49.23
- P/B (TTM)
- 4.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.40 | $-0.58 | +0.1786 | +30.87% |
|
Dec 2025 (Q4)
|
$0.29 | $0.35 | -0.0592 | -16.95% |
|
Sep 2025 (Q3)
|
$0.49 | $0.31 | +0.1834 | +59.82% |
|
Jun 2025 (Q2)
|
$0.67 | $0.39 | +0.2813 | +72.37% |
Financial Statements
| Revenues | $206.24M |
| Benefits Costs and Expenses | $252.56M |
| Cost Of Revenue | $55.74M |
| Cost Of Revenue, Goods | $55.74M |
| Costs And Expenses | $252.67M |
| Gross Profit | $150.50M |
| Nonoperating Income/Loss | $110.00K |
| Operating Expenses | $196.93M |
| Selling, General, and Administrative Expenses | $94.62M |
| Research and Development | $102.31M |
| Operating Income/Loss | -$46.43M |
| Income/Loss Before Equity Method Investments | -$46.32M |
| Income/Loss From Continuing Operations After Tax | -$45.37M |
| Income/Loss From Continuing Operations Before Tax | -$46.32M |
| Income Tax Expense/Benefit | -$947.00K |
| Net Income/Loss | -$45.37M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$45.37M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.37M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.48 |
| Basic Average Shares | 191,382,649 |
| Assets | $451.24M |
| Current Assets | $308.39M |
| Accounts Receivable | $34.58M |
| Inventory | $17.57M |
| Other Current Assets | $256.23M |
| Noncurrent Assets | $142.85M |
| Fixed Assets | $94.33M |
| Other Non-current Assets | $48.52M |
| Liabilities | $57.35M |
| Current Liabilities | $45.53M |
| Accounts Payable | $11.91M |
| Other Current Liabilities | $33.62M |
| Noncurrent Liabilities | $11.82M |
| Equity | $393.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $393.89M |
| Liabilities And Equity | $451.24M |
| Net Cash Flow From Operating Activities | -$11.31M |
| Net Cash Flow From Operating Activities, Continuing | -$11.31M |
| Net Cash Flow From Investing Activities | -$16.37M |
| Net Cash Flow From Investing Activities, Continuing | -$16.37M |
| Net Cash Flow From Financing Activities | -$26.37M |
| Net Cash Flow From Financing Activities, Continuing | -$26.37M |
| Net Cash Flow | -$54.05M |
| Net Cash Flow, Continuing | -$54.05M |
| Comprehensive Income/Loss | -$44.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$44.46M |
| Other Comprehensive Income/Loss | -$57.87M |